Synthesis and Preliminary Biological Evaluations of Fluorescent or 149 Promethium Labeled Trastuzumab-Polyethylenimine.
Biomedicines（2015）
摘要
The results indicate the DOTA-PEI-Trastuzumab compound has potential as a targeted therapeutic carrier, and future studies should be performed.
更多查看译文
关键词
Actinium-225,Promethium-149,Trastuzumab,polyethylenimine,radiotherapy,targeted therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要